Bausch & Lomb U.K Limited

Bausch & Lomb House, 106 London Road, Kingston-upon-Thames, Surrey, KT2 6TN, UK
Telephone: +44 (0)208 781 2900
Fax: +44 (0)208 781 2901
Medical Information Direct Line: +44(0)1748 828849 or 08 1871 9318
Medical Information e-mail: medicalinformationuk@bausch.com
Customer Care direct line: +44 (0)208781 2991

Summary of Product Characteristics last updated on the eMC: 30/07/2008
SPC Minims Oxybuprocaine Hydrochloride 0.4% w/v

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 30/07/2008 and displayed until Current
Reasons for adding or updating:
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-Aug-2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



Section 10 : Error in revision date:08/2006

Updated on 03/10/2005 and displayed until 30/07/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 03/10/2005 and displayed until 03/10/2005
Reasons for adding or updating:
  • Change from BAN to rINN
Updated on 15/09/2003 and displayed until 03/10/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 30/07/2001 and displayed until 15/09/2003
Reasons for adding or updating:
  • No reasons supplied
Updated on 15/02/2000 and displayed until 30/07/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 15/02/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   oxybuprocaine